Prediabetes in children and adolescents in Israel: a large-scale retrospective cohort study

Maya Gerstein1,2,3, Yael Reichenberg3, Herman Avner Cohen1,4

  • 1Pediatric Ambulatory Community Clinic, Petach Tikva, Israel.

Insights

Prediabetes is rising in Israeli youth, with higher risks found in obese children, those from the Arab sector, and lower socioeconomic backgrounds. Targeted prevention strategies are crucial for early identification and reducing future type 2 diabetes risk.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Metabolic Disorders

Background:

  • Prediabetes prevalence is increasing globally in pediatric populations.
  • Limited population-based data exist for diverse youth demographics.
  • This study addresses the gap by examining prediabetes risk factors in Israeli children and adolescents.

Purpose of the Study:

  • To determine the prevalence of impaired fasting glucose (IFG) and elevated glycated hemoglobin A1c (HbA1c) in non-diabetic Israeli youth.
  • To identify demographic and clinical factors associated with prediabetes.
  • To inform targeted prevention and screening strategies.

Main Methods:

  • Retrospective cohort study of 19,654 children aged 5-18 years (2010-2020).
  • Data included age, sex, sector, socioeconomic status (SES), BMI, fasting plasma glucose, and HbA1c.
  • IFG defined as 100-125 mg/dL; elevated HbA1c as 5.7-6.4%.

Main Results:

  • Obesity rates were higher in the 10-14 age group (44.1%).
  • IFG and/or elevated HbA1c prevalence was highest in morbidly obese individuals.
  • Low SES was linked to increased IFG odds (5-9 years) and prediabetes (10-18 years).
  • Children from the Arab sector showed higher adjusted odds of prediabetes.

Conclusions:

  • Significant disparities in prediabetes risk exist among Israeli youth.
  • Risk is influenced by sex, age, obesity, sector, and SES.
  • Supports targeted, age- and sector-specific screening and prevention strategies, addressing social determinants of health.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K